Published on November 20, 2025,
By Pawan
A 16‑week Rutgers trial in adults at risk for diabetes has found that metformin can significantly reduce the usual gains in aerobic fitness, vascular health, and glucose control that people typically get from regular exercise, possibly by altering how mitochondria adapt to training.
Experts say exercise is still essential, but patients and clinicians may need to rethink how and when metformin is used in active individuals.newatlas+4
Highlight key points
- Scientists discover metformin may block key exercise benefits: A new Rutgers‑led human trial suggests that metformin can significantly blunt expected gains in fitness, vascular health, and blood sugar control from structured exercise, especially in adults at risk for diabetes.sciencedaily+1
- Metformin reduced metabolic and cardiovascular improvements from training: Compared with placebo, metformin users showed smaller improvements in aerobic capacity, vascular insulin sensitivity, fasting glucose, and inflammatory markers after 16 weeks of supervised workouts.pharmacytimes+2
- Participants on metformin saw weaker gains in fitness, blood vessel function, and glucose control: Those exercising without the drug improved VO2max and blood vessel function, while the metformin groups often saw no fitness gains and muted vascular and glycemic changes.technologynetworks+2
- Mitochondrial effects may explain the interference: Metformin works partly by inhibiting mitochondrial activity, which may dampen the cellular stress and signaling that drive exercise‑induced adaptations in muscles and blood vessels.pmc.ncbi.nlm.nih+2
- Exercise is still essential, but personalization matters: Experts urge patients not to stop metformin on their own but to discuss individualized plans that balance medication benefits with preserving as much of exercise’s unique health impact as possible.bjsm.bmj+2
Source: Rutgers University, peer‑reviewed exercise–metformin trials, and major health news coverage.sciencedaily+2
Is Your Diabetes Pill Cancelling Your Workout Gains? New Rutgers Study Warns About Metformin and Exercise
Is Your Diabetes Pill Cancelling Your Workout Gains? New Rutgers Study Warns About Metformin and Exercise”sciencedaily+1
New research from Rutgers suggests metformin, the world’s most prescribed diabetes drug, may blunt key fitness, blood vessel, and blood sugar benefits of exercise by interfering with mitochondrial activity, raising big questions about how best to combine medication and workouts for diabetes prevention.pubmed.ncbi.nlm.nih+2
What this new metformin–exercise study found
Rutgers researchers recently ran a double‑blind, placebo‑controlled trial in adults with elevated risk for metabolic syndrome to see what happens when you pair metformin with structured exercise training.
Over 16 weeks, participants were randomly assigned to low‑ or high‑intensity aerobic exercise, combined with either metformin (up to 2,000 mg/day) or placebo.sciencedaily+2
Key finding: Metformin may block core exercise benefits
The most striking result was that metformin users did not enjoy the usual boost in cardiorespiratory fitness that comes with months of steady exercise.
In placebo groups, VO2max—a gold‑standard measure of how well the heart, lungs, and muscles use oxygen—rose significantly, but in both low‑ and
high‑intensity metformin groups, VO2max failed to improve.technologynetworks+2
Blood vessel health: gains blunted, not erased
Exercise usually improves how arteries and tiny capillaries respond to blood flow and insulin, helping lower blood pressure and reduce cardiovascular risk.
In this study, exercise alone improved these measures across intensities, confirming that both moderate and vigorous activity can remodel the vascular system in beneficial ways.pharmacytimes+2
Glucose control and inflammation: not the full win expected
One might expect that combining metformin—long hailed for its glucose‑lowering power—with exercise would lead to superior blood sugar results.
Yet the Rutgers team saw that metformin actually attenuated some of the exercise‑induced improvements in fasting glucose and inflammatory markers such as endothelin‑1 and TNF‑alpha.pmc.ncbi.nlm.nih+3
Fitness and body composition: where metformin falls short
On the fitness front, the new trial adds to a growing pattern: metformin often fails to enhance, and may even blunt, gains in aerobic capacity and muscle performance.
In healthy older adults and older people with prefrailty, previous research also found that metformin reduced the impact of resistance and aerobic training on strength and endurance outcomes.thelancet+2
Why would a diabetes drug fight exercise? The mitochondrial clue
The big question is mechanistic: how could a drug that improves average glucose control interfere with exercise, one of the best tools for diabetes prevention?
Rutgers scientists suspect the answer lies in mitochondria—the energy‑producing powerhouses inside cells that adapt strongly to physical training.pmc.ncbi.nlm.nih+2
Mitochondria, exercise, and metformin: what lab models show
Animal and cellular experiments give a deeper look at this tug‑of‑war. In high‑fat‑diet mouse models, exercise training typically restores mitochondrial efficiency, boosts antioxidant defenses, and improves insulin signaling in the brain and muscles.frontiersin+1
Not all studies agree: a messy evidence landscape
It is important to note that not every study paints metformin as an “exercise blocker.” In some trials involving people with established type 2 diabetes,
combinations of metformin and exercise have improved glucose metabolism and cardiac function compared with either treatment alone, particularly regarding left ventricular performance and overall cardiopulmonary capacity.bjsm.bmj+1
What the Rutgers authors actually concluded
The Rutgers group emphasized that exercise remains a cornerstone of diabetes prevention and cardiovascular health but warned that metformin may limit some of the metabolic, vascular, and fitness improvements normally expected from training.
They stressed that these findings do not mean patients should abandon the drug, especially those with established diabetes who rely on it to control high blood sugar.medicalnewstoday+2
What this means if you take metformin and exercise
For people using metformin for prediabetes or type 2 diabetes, these results can sound discouraging, but they should be seen as a prompt for conversation, not a reason to panic.
Exercise still improves mood, mobility, strength, balance, and many aspects of health that were not measured in the Rutgers trial, and metformin continues to have a strong safety and benefit record as a first‑line diabetes drug.foxnews+2
Practical questions to ask your doctor
If you are on metformin and committed to regular workouts, consider raising these targeted questions in your next appointment.foxnews+1
- Do the benefits of metformin clearly outweigh any potential blunting of exercise gains in my specific situation (A1C level, cardiovascular risk, weight, and fitness goals)?pmc.ncbi.nlm.nih+1
- Are there alternative or additional strategies—such as GLP‑1 receptor agonists, SGLT2 inhibitors, or lifestyle‑first approaches—that might fit my health profile and activity level?bjsm.bmj+1
- Could adjusting the timing of my metformin dose relative to my workouts reduce its impact on training adaptations, or is that not supported by evidence yet?clinicaltrials+1
Should anyone stop metformin because of this?
Experts caution strongly against stopping or changing any diabetes medication without medical supervision, even in light of provocative new data like this.
Abruptly discontinuing metformin can lead to loss of glycemic control, higher blood sugars, and increased risk of complications, especially in people with established diabetes or multiple cardiovascular risks.foxnews+2
How this challenges older diabetes prevention advice
For years, clinicians were encouraged to pair metformin with exercise on the assumption that combining two proven tools would stack their benefits for people at risk of diabetes.
The Rutgers data show the math is more complicated: in some cases, one plus one might be closer to one‑and‑a‑half, at least for certain markers like VO2max and vascular insulin sensitivity.pubmed.ncbi.nlm.nih+3
What people at risk for diabetes can do right now
If you are in the prediabetes or “high risk” category—the same type of population studied by Rutgers—this research underscores the ongoing importance of lifestyle change.
Weight management, regular aerobic activity, resistance training, and a diet rich in minimally processed foods remain the most potent tools for delaying or preventing type 2 diabetes onset.clinicaltrials+3
Limitations of the Rutgers study
Like any trial, this new research has limits that general readers and patients should keep in mind.
The study followed a relatively small group of adults for 16 weeks, which is enough time to detect changes in fitness and vascular function but not long enough to track hard outcomes like heart attacks, strokes, or diabetes diagnoses.newatlas+2
The bigger picture: exercise remains irreplaceable
Even with metformin potentially blunting some specific metrics, no pill can replicate the full spectrum of exercise benefits.
Regular physical activity improves muscle mass, bone density, mental health, sleep, and functional independence in ways that go far beyond glucose numbers or artery measurements.thelancet+2
Trusted Source Tag :
- https://www.rutgers.edu/news/why-your-daily-walk-might-not-work-well-if-youre-metformin
- https://www.sciencedaily.com/releases/2025/11/251117095648.htm
- https://www.medicalnewstoday.com/articles/metformin-diabetes-lower-exercise-benefits
- https://pubmed.ncbi.nlm.nih.gov/41160096/
- https://newatlas.com/diabetes/diabetes-medication-fitness/
- https://www.pharmacytimes.com/view/metformin-may-diminish-the-cardiometabolic-benefits-of-exercise
- https://www.technologynetworks.com/drug-discovery/news/metformin-cancels-out-exercise-benefits-406820
- https://www.empr.com/news/metformin-blunts-exercise-mediated-increases-in-insulin-sensitivity/
- https://academic.oup.com/jcem/advance-article-abstract/doi/10.1210/clinem/dgaf551/8276136
- https://pmc.ncbi.nlm.nih.gov/articles/PMC4906084/
- https://www.frontiersin.org/journals/endocrinology/articles/10.3389/fendo.2020.00519/full
- https://www.thelancet.com/journals/lanhl/article/PIIS2666-7568(25)00014-5/fulltext?rss=yes
- https://pmc.ncbi.nlm.nih.gov/articles/PMC6795285/
- https://bjsm.bmj.com/content/58/23/1452
- https://www.foxnews.com/health/popular-diabetes-drug-could-block-exercise-benefits-new-study-warns
- https://clinicaltrials.gov/study/NCT03355469
- https://www.news-medical.net/news/20251107/Diabetes-drug-blunts-exercise-induced-health-improvements.aspx
- https://www.instagram.com/reel/DRQJfCbjwBE/
- https://timesofindia.indiatimes.com/life-style/health-fitness/health-news/diabetes-drug-cancelling-your-workout-gains-study-explains-why/articleshow/125200096.cms
- https://www.adcesconnect.org/newjerseycoordinatingbody/blogs/geraldine-pierre/2025/11/09/new-research-why-your-daily-walk-might-not-work-as

